相关实验视频

Updated: Jul 16, 2025

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

玻尿酸毒素在胃肠道中的使用:经过三十年的重新评估

Wasay A Mohajir^1,2, Shruti Khurana², Khushboo Singh²

¹Department of Gastroenterology, Texas A&M College of Medicine and Baylor Scott & White Medical Center, Round Rock, Texas.

Gastroenterology & hepatology

|September 14, 2023

概括

毒素A (BTX) 由于其肌肉放松作用,对各种胃肠道 (GI) 疾病有前途. 然而,有限的长期数据和疗效限制了其在GI条件下的广泛临床应用.

科学领域:

胃肠病学胃肠病学
胃肠道运动障碍胃肠道运动障碍
药理学药理学是指药理学的学科.

背景情况:

毒素A (BTX) 已经在各种医疗条件中显示出治疗潜力.
它在胃肠道 (GI) 中的应用已被研究了三十年.
BTX以其安全性,易于使用以及降低肌肉强度的能力而闻名.

研究的目的:

综合审查有关BTX在各种胃肠道疾病中的疗效的现有文献.
评估证据的强度,并为BTX在特定GI条件下使用提供建议.
确定关于胃肠病学BTX的未来研究的局限性和领域.

主要方法:

在多个数据库 (PubMed,Embase,Cochrane图书馆等) 进行系统的文献搜索. ) 的情况.
包括从病例系列到随机对照试验的研究.
分析数据,重点关注BTX的疗效,安全性和GI应用的临床建议.

主要成果:

对BTX的疗效进行了评估,包括阿喀拉西亚,胃衰竭,裂和肥胖等疾病.
积极的发现支持BTX在某些运动障碍中的使用,而对其他疾病的数据仍然有限.
审查强调BTX在减少肌肉度方面的好处,但指出对长期有效性的担忧.

结论:

对于特定的胃肠道疾病,特别是那些涉及肌肉强度的疾病,BTX提供了一个安全有效的选择.
需要进一步进行高质量的研究,包括长期研究,以巩固BTX在管理更广泛的胃肠道疾病方面的作用.
目前的证据支持BTX的谨慎应用,明确指示并考虑其局限性.

关键词:

毒素A是一种毒素.亚喀拉西亚亚喀拉西亚是一个亚洲地区.通过内镜检查 (endoscopy) 进行内镜检查消化道的食道裂裂是一个裂.胃肠衰竭是因为胃肠衰竭.肥胖肥胖肥胖肥胖肥胖肥胖肥胖肥胖奥迪神经的疾病疾病

更多相关视频

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

相关概念视频

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...

Gastrointestinal Motility Disorders

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...

Depolarizing Blockers: Pharmocokinetics

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...